Yokokawa, Tetsuro http://orcid.org/0000-0001-8197-3274
Kunii, Hiroyuki
Kaneshiro, Takashi
Ichimura, Shohei
Yoshihisa, Akiomi
Yashiro Furuya, Makiko
Asano, Tomoyuki
Nakazato, Kazuhiko
Ishida, Takafumi
Migita, Kiyoshi
Takeishi, Yasuchika
Article History
Received: 2 December 2018
Accepted: 24 March 2019
First Online: 2 April 2019
Ethics approval and consent to participate
: This study was approved by the ethics committee of Fukushima Medical University and written informed consent was provided by the patient.
: Consent for publication was obtained by the patient in written form.
: Tetsuro Yokokawa belongs to a department supported by Actelion Pharmaceuticals Japan Ltd. Akiomi Yoshihisa belongs to a department supported by Fukuda Denshi Co, Ltd. These companies are not associated with the contents of this study. No other authors have competing interests associated with this study.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.